iSERA Lifesciences Ltd
₹143.90▲ +0.00 (+0.00%)
ISERA·BSE·Information Technology
Market Cap
121.01 Cr
PE Ratio
464.19
Volume
31
Day High - Low
143.90 - 143.90
52W High-Low
151.05 - 8.96
₹143.90▲ +0.00 (+0.00%)
Market Cap121.01 Cr
PE Ratio464.19
Volume31
Day High - Low143.90 - 143.90
52W High-Low151.05 - 8.96
iSERA Lifesciences Ltd (ISERA): company summary
The company's annual revenue is ₹1 crore, but net profit is ₹0 crore, with a net profit margin of 19.1% compared to 44.4% a year earlier.
iSERA Lifesciences Ltd (ISERA) is a micro-cap Information Technology company valued at ₹121 crore operating in Computer Software & Consulting on the NSE and BSE.
- Recent price move
- iSERA Lifesciences Ltd last traded at ₹143.9, unchanged on the day.
- Financial performance
- The company's annual revenue is ₹1 crore, but net profit is ₹0 crore, with a net profit margin of 19.1% compared to 44.4% a year earlier. The latest quarter shows a net profit loss of ₹0 crore, which widened from ₹0 crore in the same quarter a year ago.
- Valuation multiples
- The stock trades at 464.2 times earnings, a premium to the Information Technology median of 20.5, 14.67 times book value.
- Things to watch
- The company's net profit margin has narrowed by 25.3 percentage points, and the latest quarter's net profit loss widened from ₹0 crore to ₹0 crore. The stock is 4.7% below its 52-week high.
- Where it stands
- The company remains unprofitable, with net profit at ₹0 crore for the latest quarter and annual net profit at ₹0 crore. The stock is 4.7% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.0/10
Poor
Fair Value
Sign in to see
ROE
3.15%
Weak
P/E
464.19x
Expensive
Debt / Equity
0.00
Low
Industry
Information Technology
Computer Software & Consulting
Overall View
Mixed
Price performance
52W₹8.96
₹151.05
DocStoX take
Supported by momentum (7.5), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0 and growth at 1.5 and quality at 2.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence3.0
/10
Poor
Quality
Weak
ROE 3.1%
Valuation
Expensive
P/E 200.0×
Growth
Flat
Revenue -8.6% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Strong
95% of 52-week range
At a glance
Market Cap
₹121 Cr
52W High / Low
₹151 / ₹9
Dividend Yield
0.00%
Promoter Holding
58.63%
EPS (TTM)
₹0.31
Book Value
₹9.81
Key highlights
- Low leverage — D/E 0.00
- Healthy net margin (19%)
- Profit shrinking 32% a year
- Revenue shrinking 9% a year
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Information Technology stocks · Computer Software & Consulting
Explore iSERA Lifesciences Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
iSERA Lifesciences Ltd peers in Information Technology
Other Information Technology stocks on the NSE & BSE. See the full Information Technology sector list.
Related tools & concepts
Value iSERA Lifesciences Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing